World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
47670
World Ranking
7553
National Ranking
739

Overview

Sarah E Pinder is affiliated with King's College London in the United Kingdom and has an extensive publication record focused primarily on cancer research and related biomedical fields.

Their research spans several main fields of study including Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader disciplines, they have concentrated on subfields such as Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, and Molecular Biology.

The main topics covered in their work include:

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Global Cancer Incidence and Screening
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • AI in cancer detection
  • Cancer Immunotherapy and Biomarkers

Among their recent academic papers are:

  • Spatial genomics maps the structure, nature and evolution of cancer clones, 2022, Nature
  • Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast Cancer, 2021, Cancer Research
  • Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer, 2022, Nature Genetics
  • Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer, 2021, Modern Pathology
  • Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression, 2021, Science Advances

They have frequently published in venues including Cancer Research, European Journal of Surgical Oncology, British Journal of Cancer, Clinical Cancer Research, and bioRxiv (Cold Spring Harbor Laboratory).

Their collaboration network includes frequent co-authors such as Alastair M. Thompson, Abeer M. Shaaban, Elinor J. Sawyer, Hilary Stobart, and Anita Grigoriadis.

Best Publications

  • The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

    Christina Curtis;Christina Curtis;Sohrab P Shah;Suet-Feung Chin;Gulisa Turashvili

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Pathological prognostic factors in breast cancer.

    Christopher W. Elston;Ian O. Ellis;Sarah E. Pinder

  • The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes

    Bernard Pereira;Suet Feung Chin;Oscar M. Rueda;Hans Kristian Moen Vollan

  • Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: The TNT Trial

    Andrew Tutt;Andrew Tutt;Holly Tovey;Maggie Chon U Cheang;Sarah Kernaghan

  • High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

    Dalia M. Abd El-Rehim;Graham Ball;Sarah E. Pinder;Emad Rakha

  • Expression of luminal and basal cytokeratins in human breast carcinoma

    Dalia M Abd El-Rehim;Sarah E Pinder;Claire E Paish;J Bell

  • Lancet Oncol 10

    Jack Cuzick;Ivana Sestak;Sarah E. Pinder;Ian O. Ellis

  • Terahertz pulsed spectroscopy of freshly excised human breast cancer

    Philip C. Ashworth;Emma Pickwell-MacPherson;Elena Provenzano;Sarah E. Pinder

  • An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

    Andrew E Teschendorff;Ahmad Miremadi;Sarah E Pinder;Ian O Ellis

  • Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

    Jack Cuzick;Ivana Sestak;Sarah E Pinder;Ian O Ellis

  • Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients.

    Robin Stuart-Harris;C Caldas;S Pinder;P Pharoah

  • Histological grading of breast carcinomas: A study of interobserver agreement

    P Robbins;P Robbins;S Pinder;S Pinder;N de Klerk;N de Klerk;H Dawkins;H Dawkins

  • Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    Y S Ju;L B Alexandrov;M Gerstung;I Martincorena

  • High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

    Suet F Chin;Andrew E Teschendorff;John C Marioni;Yanzhong Wang

  • Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer

    Julia Margaret Wendy Gee;J. F. Robertson;E. Gutteridge;I. O. Ellis

  • Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up

    S.E. Pinder;I.O. Ellis;M. Galea;S. O'rouke

  • Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

    Thomas C Putti;Dalia M Abd El-Rehim;Emad A Rakha;Claire E Paish

  • Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

    Peter T Simpson;Theo Gale;Jorge S Reis-Filho;Chris Jones

  • Addressing overtreatment of screen detected DCIS; the LORIS trial

    Adele Francis;Jeremy Thomas;Lesley Fallowfield;Matthew Wallis

Frequent Co-Authors

Ian O. Ellis
Ian O. Ellis University of Nottingham
Andrew Evans
Andrew Evans University of Dundee
C.W. Elston
C.W. Elston University of Nottingham
Roger W. Blamey
Roger W. Blamey Nottingham City Hospital
John M. S. Bartlett
John M. S. Bartlett University of Toronto
Fiona J. Gilbert
Fiona J. Gilbert University of Cambridge
Luke Vale
Luke Vale Newcastle University
Christophe Fraser
Christophe Fraser University of Oxford
John F.R. Robertson
John F.R. Robertson University of Nottingham
Andrew Tutt
Andrew Tutt Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking alternative or complementary career routes to studying Medicine in the USA, online degrees offer flexibility and a range of professional opportunities. One relevant choice is online nutrition degree programs, which can lead to rewarding roles in clinical nutrition, wellness coaching, and public health education.

For those aiming at leadership or administrative roles in healthcare, pursuing one of the top cahme-accredited mha programs can pave the way toward management positions in hospitals, clinics, or health systems.

Registered Nurses looking to advance can consider rn to bsn no clinical hours programs, designed for working RNs who want to complete their Bachelor of Science in Nursing online without additional in-person requirements.

For those at the pinnacle of nursing, there are dnp programs online that offer advanced practice and leadership training, with flexible formats ideal for busy professionals.

Each of these online pathways provides convenient, accredited options for building a dynamic healthcare career—without the need to commit to a traditional medical degree.

Best Scientists Citing Sarah E Pinder

Trending Scientists